Department of Medicine

Vanderbilt research uncovers new clue to insulin resistance

The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.

New analytical approach identifies novel risk genes for colorectal cancer

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

‘Liberation’ from acute dialysis may enhance recovery of kidney function

Researchers at Vanderbilt Health and three other centers compared conventional dialysis to a conservative dialysis strategy.

Vanderbilt Health’s Vineet Agrawal, Fabian Bock among 2026 ASCI Young Physician-Scientist awardees

Since 2014, 27 Vanderbilt faculty members have received the annual award, which recognizes “notable achievements” by researchers early in their first faculty appointments.

(iStock)

Clinical trial led by Vanderbilt Health seeks to refine lung cancer biopsy standards

The development of better biopsy approaches is driven by the fact that lung cancer kills more than 130,000 Americans annually, and survival depends on early diagnosis, which requires biopsy to be definitive.

Stokes Peebles, MD, right, Mark Rusznak, PhD, and their colleagues have identified a potential drug target for treating asthma. (photo by Erin O. Smith)

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

1 2 3 125